COMMUNIQUÉS West-GlobeNewswire

Viveve Initiates LIBERATE-International Trial for Improvement of Stress Urinary Incontinence
14/08/2018
Company also receives regulatory clearance in Argentina for treatment of urinary incontinence Confirms intent to submit IDE to FDA for LIBERATE-U.S. in the third quarter ENGLEWOOD, Colo., Aug. 14, 2018 (GLOBE NEWSWIRE [...]
BioSig Technologies Announces FDA 510(k) Clearance for PURE EP System
14/08/2018
Santa Monica, CA, Aug. 14, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), announced that the Company has received 510(k) clearance for its first product, PURE EP System, from the U.S. Food and Drug [...]
Spero Announces Appointment of John C. Pottage, Jr., MD to its Board of Directors
14/08/2018
Spero adds broad leadership and scientific expertise to its Board of Directors with appointment of John Pottage CAMBRIDGE, Mass., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset [...]
NanoMedical Systems Receives $3M Grant to Advance nStrada™ Implantable Nanofluidics System for Long-Term Treatment of Opioid Use Disorder
14/08/2018
AUSTIN, Texas, Aug. 14, 2018 (GLOBE NEWSWIRE) -- NanoMedical Systems, Inc. (NMS), an Austin-based company developing implantable, sustained-release, drug-delivery devices based on its nStrada™ nanofluidics platform has [...]
Timothy Keeler, BS-PA is Selected to the American Health Council’s Board of Physicians
14/08/2018
NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- The American Health Council selected Timothy Keeler, BS-PA to its Board of Physicians. Mr. Keeler currently holds various leadership roles, including vice-president of [...]
Galectin Therapeutics Reports 2018 Second Quarter Financial Results and Provides Business Update
14/08/2018
NORCROSS, Ga., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results for its second fiscal [...]
Spectral Announces Second Quarter Results
14/08/2018
TORONTO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX: EDT) , a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced its [...]
Precision Therapeutics Investee, Helomics Corporation, Announces Commercial Launch of New ‘HelomicsDiscover’ Program to Drive Forward the Next Generation of Precision Cancer Therapies
14/08/2018
MINNEAPOLIS, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]
Inovio Announces First Patient Dosed in Trial to Determine PENNVAX®-GP’s Ability to Induce Remission of HIV Infection
14/08/2018
HIV Trial Will Be Fully Funded by $6.9 Million National Institutes of Health Grant PLYMOUTH MEETING, Pa., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that the first [...]
Genacol Canada Corporation and Tetra Bio-Pharma Team Up to bring Innovative Cannabinoid Treatments to Self-Care Market in Canada
14/08/2018
ORLEANS, Ontario, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to announce that they have concluded [...]
Genacol Canada Corporation et Tetra Bio-Pharma s'associent pour introduire des traitements innovants aux cannabinoïdes dans le marché des soins auto-administrés au Canada
14/08/2018
ORLEANS, Ontario, 14 août 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., un chef de file dans la découverte et le développement de médicaments à base de cannabinoïdes (TSX VENTURE: TBP) (OTCQB: TBPMF), est heureuse d’ [...]
Imagin Medical Reports Fiscal 2018 Third Quarter Results
14/08/2018
VANCOUVER, B.C. and BOSTON, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt:DPD2) (Stuttgart:DPD2) (“Imagin” or the “Company”) today reported financial results for the three months [...]
Cue Biopharma to Host Investor Business Update Call and Webcast
14/08/2018
Update on progress of selective immune modulation platform CAMBRIDGE, Mass., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, proprietary [...]
Onconova Therapeutics Reports Business Highlights and Financial Results for Second Quarter 2018
14/08/2018
NEWTOWN, Pa., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) , a Phase 3 stage biopharmaceutical company focused on developing rigosertib, a novel small molecule drug candidate to treat [...]
CymaBay Therapeutics to Participate in Upcoming Investor Conferences in August and September
14/08/2018
NEWARK, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]
scPharmaceuticals Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update
14/08/2018
Request for Type A meeting was granted by the U.S. Food and Drug Administration to discuss the Complete Response Letter received in June 2018 Balance sheet remains strong with over $100 million in cash BURLINGTON, Mass [...]
CLS Holdings USA Issues Chairman’s Update
14/08/2018
Seeking Expansion Beyond Nevada Exploring to License the Proprietary Extraction and Conversion Processing LAS VEGAS, Aug. 14, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a diversified cannabis [...]
Chiesi Foundation Onlus Issues 2018 Call for Scientific Research Proposals
14/08/2018
Scientists and researchers are invited to submit proposals for Research in neonatology and pulmonology CARY, N.C., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Chiesi Foundation Onlus (key-A-zee) announced its 2018 Call for [...]
AIT Therapeutics Reports Financial Results for First Fiscal Quarter 2019
14/08/2018
Started commercial development of ventilator compatible NO generator and delivery system -- FDA 510(k) submission expected in the first quarter of calendar 2019 Human and in-vitro Nitric Oxide (NO) data presented at the [...]

Pages